Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP315451.RAzGUsH4Pq13qNpc3Z7_IcSS5ffWkv1RpKjKcKeAzQmhQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP315451.RAzGUsH4Pq13qNpc3Z7_IcSS5ffWkv1RpKjKcKeAzQmhQ130_assertion type Assertion NP315451.RAzGUsH4Pq13qNpc3Z7_IcSS5ffWkv1RpKjKcKeAzQmhQ130_head.
- NP315451.RAzGUsH4Pq13qNpc3Z7_IcSS5ffWkv1RpKjKcKeAzQmhQ130_assertion description "[Current therapy of haemophilia is based on factor VIII (FVIII) or factor IX (FIX) replacement therapy including prophylactic or demand protocols of fixed-dose, and as future alternative, gene and cell therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP315451.RAzGUsH4Pq13qNpc3Z7_IcSS5ffWkv1RpKjKcKeAzQmhQ130_provenance.
- NP315451.RAzGUsH4Pq13qNpc3Z7_IcSS5ffWkv1RpKjKcKeAzQmhQ130_assertion evidence source_evidence_literature NP315451.RAzGUsH4Pq13qNpc3Z7_IcSS5ffWkv1RpKjKcKeAzQmhQ130_provenance.
- NP315451.RAzGUsH4Pq13qNpc3Z7_IcSS5ffWkv1RpKjKcKeAzQmhQ130_assertion SIO_000772 21396685 NP315451.RAzGUsH4Pq13qNpc3Z7_IcSS5ffWkv1RpKjKcKeAzQmhQ130_provenance.
- NP315451.RAzGUsH4Pq13qNpc3Z7_IcSS5ffWkv1RpKjKcKeAzQmhQ130_assertion wasDerivedFrom befree-20140225 NP315451.RAzGUsH4Pq13qNpc3Z7_IcSS5ffWkv1RpKjKcKeAzQmhQ130_provenance.
- NP315451.RAzGUsH4Pq13qNpc3Z7_IcSS5ffWkv1RpKjKcKeAzQmhQ130_assertion wasGeneratedBy ECO_0000203 NP315451.RAzGUsH4Pq13qNpc3Z7_IcSS5ffWkv1RpKjKcKeAzQmhQ130_provenance.